arrow
E

Elisabetta Mereu

ciberehd
H指数:29
被引数:3,919

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma

MDM2驱动蛋白酶体抑制剂耐药性,并在多发性骨髓瘤中代表一种TP53非依赖性的治疗易损性

Cells
IF5.2
2026-05-010
OA
Common genomic and transcriptomic signatures in Richter transformation highlight druggable vulnerabilities and guide drug repurposing strategies

Richter转化的共同基因组学和转录组学特征突显可用药脆弱性并指导药物重定位策略

Leukemia
IF13.4
2026-04-140
OAAI
Systematic evaluation of single-cell multimodal data integration enhances cell type resolution and discovery of clinically relevant states in complex tissues

单细胞多模式数据整合的系统评估可增强细胞类型分辨率并发现复杂组织中的临床相关状态

2026-03-130
OAAI
PLA2G2D+and SPP1+macrophages tailor lymphoid and granuloma niche architecture in Inflammatory Bowel Disease

PLA2G2D+和SPP1+巨噬细胞调控炎症性肠病中淋巴组织和肉芽肿微环境的结构

2026-01-010
PRE
The multiomics blueprint of the individual with the most extreme lifespan

具有最极端寿命个体的多组学蓝图

2025-09-240
OAAI
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias

CD19-CARpos和CARneg T细胞的整合单细胞多组学提示b细胞肿瘤中免疫治疗反应的驱动因素

2024-11-010
OAAI
IκBα controls dormancy in hematopoietic stem cells via retinoic acid during embryonic development
2024-06-012
OAAI
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease (vol 14, 4506, 2023)
2024-01-290
OAAI
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma

溶素 (K) 特异性脱甲基酶1抑制增强蛋白酶体抑制剂反应并克服多发性骨髓瘤的耐药性

2023-08-105
OAAI
Targeting lymphoid-derived IL-17 signaling to delay skin aging

靶向淋巴源性IL-17信号通路延缓皮肤衰老

2023-06-0822
OAAI
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin

胶质母细胞瘤细胞的命运受肿瘤体积和浸润边缘的微环境的差异调节

2023-05-0120
OA
Single-cell multiomics analysis of myelodysplastic syndrome predicts clinical response to DNA methylation inhibitor therapy

骨髓增生异常综合征的单细胞多组学分析预测DNA甲基化抑制剂治疗的临床反应

2023-04-140
PRE
A single-cell tumor immune atlas for precision oncology
2021-09-2185
OA